Delivery Order SPE2DB22D1106-SPE2DB24FFKP1

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,777.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,567,875,733 units of CYANOKIT 5 gram vials and has an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,360.83, is for the supply of 4,568,108,068 units of the CYANOKIT 5 gram vials. The award has an ultimate completion date of May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical,...
This federal contract award, valued at $2,643.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D2211|SPE2DB25FRWAB) for 4,568,053,685 units of the CYANOKIT 5 GRAM VIALS medical product, with a performance period extending through April 29, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide 4,565,477,003 units of CYANOKIT 5 gram vials. The delivery order has a ceiling value of $2,337.97 and is a firm fixed-price contract. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a $6,642.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 gram vials, a specialized medical product, with a period of performance through May 19, 2025. The contract is not designated as a set-aside and is therefore open to full and open competition. AmerisourceBergen Drug Corp also holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOKIT 5 gram vials, with a ceiling value of $5,462.96 and a period of performance through July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,481,613 CYANOKIT 5 gram vials, a critical medical product used for the treatment of cyanide poisoning. The delivery order has a ceiling value of $2,418.12 and a completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.85 firm-fixed-price delivery order is for CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has an ultimate completion date of July 1, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOKIT 5 gram vials, with a total ceiling value of $1,321.56 and a performance period ending on July 1, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 gram vials, a medical product used in the treatment of cyanide poisoning. The contract has a firm fixed price, with a ceiling value of $1,982.31, and a period of performance through July 1, 2025. The contract is not set aside and is open to full and open...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFKP1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,418.12 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company, for the supply of 4565654300 CYANOKIT 5 gram vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is intended to be completed by September 4, 2024.

Generated 12/3/24, 10:08 AM